House of Lords Business
Show full summary

Lord Warner to ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 18 January (HL4659), whether, after exit from the EU, the licensing regime for medical isotopes will be the responsibility of the Medicines and Healthcare Products Regulatory Agency (MHRA) even where those isotopes are manufactured outside the UK; and if so, how the MHRA will ensure the safety of manufacture outside the Euratom framework.  HL4974

Question HL4974: tabled on 22 January 2018 and due for answer by 5 February 2018

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Warner to ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 18 January (HL4659), whether, after exit from the EU, the licensing regime for medical isotopes will be the responsibility of the Medicines and Healthcare Products Regulatory Agency (MHRA) even where those isotopes are manufactured outside the UK; and if so, how the MHRA will ensure the safety of manufacture outside the Euratom framework.  HL4974
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Monday 5 February 2018

Member's Registered Interests

There are no interests to show.

Main Member

Lord Warner
Crossbench
Life peer